Susan Hasty, Publisher
Table of Contents . . . April 19th, 1999
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Blood Weekly | Other Publications
Prion Proteins - PrP May Have Role in Copper Metabolism
Bone Marrow Transplantation - Increase Risk of Chronic GVHD with Busulfan
CMV - pp67 mRNA Disappearance May Determine Termination of Antiviral Therapy
Leishmaniasis - IgG3 Has Potential As a Diagnostic Marker
Multiple Myeloma - Idiotype Immunization May Be Beneficial
Serodiagnosis (Lyme Disease) - Protein Can Improve Sensitivity of Early Testing
Stem Cells - CD34+ Cell System May Improve Future of Immunotherapy
Tissue Reconstruction - Prefabricated Flaps Permit Blood Flow
Testing (TB) - Whole-Blood IFN-gamma Method Shows Poor Agreement with TST
Virology (HCV) - Genotype Changes Common in Hemophiliacs
Cardiovascular Disease - Survival with Congestive Heart Failure Longer for Women
Immunology - Chemical Contaminants May Inhibit White Blood Cells
Screening - American Red Cross Launches Genetic Technology to Detect Viruses
Diagnostics - "Detection Incidence of Circulating Cancer Cells from Prostate Cancer Patients' Blood."
HLA Matching - "HLA Mismatch Acceptability in Kidney Transplantation."
Hematopoietic Recovery - "A Controlled Trial of Filgrastim for Acceleration of Neutrophil Recovery after Allogeneic Blood Stem Cell Transplantation."
Pathogenesis (Angiogenesis) - "Reconstitution of Angiogenesis by Transplantation and Engraftment of Ex Vivo Expanded Human Ac133+cd34+kdr+ Endothelial Progenitor Cells. D
Blood Safety - "A Cluster of Transfusion-Associated Babesiosis Cases Traced to a Single Asymptomatic Donor."
Bone Marrow Transplantation - "Pulmonary Infections After Bone Marrow Transplantation: Clinical and Radiographic Findings."
Stem Cell Transplantation - "Autologous Blood Stem Cell Transplantation for Acute Myeloblastic Leukemia in First Complete Remission. Intensification Therapy Before Transplantation Does Not Prolong Disease-Free Survival."
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.